{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:02:50Z","timestamp":1790798570958,"version":"4.1.0"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1248\/bpb.b20-00991","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:08:14Z","timestamp":1630447694000},"page":"1230-1238","source":"Crossref","is-referenced-by-count":10,"title":["Synthesis and Biological Evaluation of Salicylic Acid Analogues of Celecoxib as a New Class of Selective Cyclooxygenase-1 Inhibitor"],"prefix":"10.1248","volume":"44","author":[{"given":"Sung-Hwa","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Yeon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Applied Life Sciences and Integrated Bioscience, Konkuk University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung-ryoung","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kug","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Applied Life Sciences and Integrated Bioscience, Konkuk University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunha","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Park","sequence":"additional","affiliation":[{"name":"Molecular Science and Technology Research Center, Ajou University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hinz B, Brune K. Cyclooxygenase-2 10 years later. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>300<\/b>, 367\u2013375 (2002).","DOI":"10.1124\/jpet.300.2.367"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. <i>J. Clin. Invest.<\/i>, <b>107<\/b>, 1491\u20131495 (2001).","DOI":"10.1172\/JCI13271"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dennis EA. Phospholipase A2 in eicosanoid generation. <i>Am. J. Respir. Crit. Care Med.<\/i>, <b>161<\/b> (Suppl. 1), S32\u2013S35 (2000).","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic acid oxygenation by COX-1 and COX-2: mechanisms of catalysis and inhibition. <i>J. Biol. Chem.<\/i>, <b>274<\/b>, 22903\u201322906 (1999).","DOI":"10.1074\/jbc.274.33.22903"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. <i>J. Biol. Chem.<\/i>, <b>275<\/b>, 32775\u201332782 (2000).","DOI":"10.1074\/jbc.M003504200"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>88<\/b>, 2692\u20132696 (1991).","DOI":"10.1073\/pnas.88.7.2692"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fitzpatrick FA, Soberman R. Regulated formation of eicosanoids. <i>J. Clin. Invest.<\/i>, <b>107<\/b>, 1347\u20131351 (2001).","DOI":"10.1172\/JCI13241"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shin SJ, Noh C, Lim SG, Lee KM, Lee KJ. Non-steroidal anti-inflammatory drug-induced enteropathy. <i>Intest. Res.<\/i>, <b>15<\/b>, 446\u2013455 (2017).","DOI":"10.5217\/ir.2017.15.4.446"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Abdellatif KRA, Fadaly WAA, Ali WAM, Kamel GM. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives. <i>J. Enzyme Inhib. Med. Chem.<\/i>, <b>31<\/b> (Suppl. 3), 54\u201360 (2016).","DOI":"10.1080\/14756366.2016.1201815"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Uddin MJ, Praveen Rao PN, Knaus EE. Design and synthesis of (Z)-1,2-diphenyl-1-(4-methanesulfonamidophenyl)alk-1-enes and (Z)-1-(4-azidophenyl)-1,2-diphenylalk-1-enes: novel inhibitors of cyclooxygenase-2 (COX-2) with anti-inflammatory and analgesic activity. <i>Bioorg. Med. Chem.<\/i>, <b>13<\/b>, 417\u2013424 (2005).","DOI":"10.1016\/j.bmc.2004.10.017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ren SZ, Wang ZC, Zhu XH, Zhu D, Li Z, Shen FQ, Duan YT, Cao H, Zhao J, Zhu HL. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition. <i>Bioorg. Med. Chem.<\/i>, <b>26<\/b>, 4264\u20134275 (2018).","DOI":"10.1016\/j.bmc.2018.07.022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhou S, Yang S, Huang G. Design, synthesis and bioactivities of celecoxib analogues or derivatives. <i>Bioorg. Med. Chem.<\/i>, <b>25<\/b>, 4887\u20134893 (2017).","DOI":"10.1016\/j.bmc.2017.07.038"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Abdelazeem AH, El-Saadi MT, Safi El-Din AG, Omar HA, El-Moghazy SM. Design, synthesis and analgesic\/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1. <i>Bioorg. Med. Chem.<\/i>, <b>25<\/b>, 665\u2013676 (2017).","DOI":"10.1016\/j.bmc.2016.11.037"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tanaka A, Hase S, Miyazawa T, Takeuchi K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>300<\/b>, 754\u2013761 (2002).","DOI":"10.1124\/jpet.300.3.754"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bottone FG Jr, Martinez JM, Alston-Mills B, Eling TE. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. <i>Carcinogenesis<\/i>, <b>25<\/b>, 349\u2013357 (2004).","DOI":"10.1093\/carcin\/bgh016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Vitale P, Perrone MG, Malerba P, Lavecchia A, Scilimati A. Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles. <i>Eur. J. Med. Chem.<\/i>, <b>74<\/b>, 606\u2013618 (2014).","DOI":"10.1016\/j.ejmech.2013.12.023"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cingolani G, Panella A, Perrone MG, Vitale P, Di Mauro G, Fortuna CG, Armen RS, Ferorelli S. Structural basis for selective inhibition of cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6). <i>Eur. J. Med. Chem.<\/i>, <b>138<\/b>, 661\u2013668 (2017).","DOI":"10.1016\/j.ejmech.2017.06.045"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Balaji B, Hariharan S, Shah DB, Ramanathan M. Discovery of potential and selective COX-1 inhibitory leads using pharmacophore modelling, <i>in silico<\/i> screening and <i>in vitro<\/i> evaluation. <i>Eur. J. Med. Chem.<\/i>, <b>86<\/b>, 469\u2013480 (2014).","DOI":"10.1016\/j.ejmech.2014.09.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yoon J, Cho L, Lee SK, Ryu J. Syntheses of 1,2,3-triazolyl salicylamides with inhibitory activity on lipopolysaccharide-induced nitric oxide production. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>21<\/b>, 1953\u20131957 (2011).","DOI":"10.1016\/j.bmcl.2011.02.034"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) G\u00f3recki T, Patonay G, Strekowski L, Chin R, Salazar N. Synthesis of novel near-infrared cyanine dyes for metal ion determination. <i>J. Heterocycl. Chem.<\/i>, <b>33<\/b>, 1871\u20131876 (1996).","DOI":"10.1002\/jhet.5570330652"},{"key":"21","unstructured":"21) Penning TD, Talley JJ, Bertenshaw SR, <i>et al.<\/i> Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1<i>H<\/i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). <i>J. Med. Chem.<\/i>, <b>40<\/b>, 1347\u20131365 (1997)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lee C, Liao J, Chen S, Yen C, Lee Y, Huang S, Huang S, Lin C, Chang VH. Fluorine-modified rutaecarpine exerts cyclooxygenase-2 inhibition and anti-inflammatory effects in lungs. <i>Front. Pharmacol.<\/i>, <b>10<\/b>, 91 (2019).","DOI":"10.3389\/fphar.2019.00091"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Iman K, Mirza MU, Mazhar N, Vanmeert M, Irshad I, Kamal MA. <i>In silico<\/i> structure-based identification of novel acetylcholinesterase inhibitors against Alzheimer\u2019s disease. <i>CNS Neurol. Disord. Drug Targets<\/i>, <b>17<\/b>, 54\u201368 (2018).","DOI":"10.2174\/1871527317666180115162422"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. <i>Eur. J. Med. Chem.<\/i>, <b>171<\/b>, 25\u201337 (2019).","DOI":"10.1016\/j.ejmech.2019.03.036"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lobo MM, Oliveira SM, Brusco I, Machado P, Timmers LFSM, de Souza ON, Martins MAP, Bonacorso HG, dos Santos JM, Canova B, da Silva TVF, Zanatta N. Regioselectively controlled synthesis of 3(5)-(trifluoromethyl) pyrazolylbenzenesulfonamides and their effects on a pathological pain model in mice. <i>Eur. J. Med. Chem.<\/i>, <b>102<\/b>, 143\u2013152 (2015).","DOI":"10.1016\/j.ejmech.2015.07.036"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM. Mechanism of selective inhibition of the inducible isoform of prostaglandin G\/H synthase. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>91<\/b>, 11202\u201311206 (1994).","DOI":"10.1073\/pnas.91.23.11202"},{"key":"27","unstructured":"27) Copeland RA, Williams JM, Rider NL, VanDyk DE, Giannaras J, Nurburg S, Covington M, Pinto D, Magolda RL, Trzaskos JM. Selective time dependent inhibition of cyclooxygenase-2. <i>Med. Chem. Res.<\/i>, <b>5<\/b>, 384\u2013393 (1995)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ouellet M, Percival MD. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. <i>Biochem. J.<\/i>, <b>306<\/b>, 247\u2013251 (1995).","DOI":"10.1042\/bj3060247"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. <i>Biochem. J.<\/i>, <b>305<\/b>, 479\u2013484 (1995).","DOI":"10.1042\/bj3050479"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ragab FA, Heiba HI, El-Gazzar MG, Abou-Seri SM, El-Sabbagh WA, El-Hazek RM. Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors. <i>Med. Chem. Commun.<\/i>, <b>7<\/b>, 2309\u20132327 (2016).","DOI":"10.1039\/C6MD00367B"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chen Z, Wang Z, Yan X, Wang P, Lu X, Chen L, Zhu H, Zhang H. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1\/COX-2 inhibitors. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>25<\/b>, 1947\u20131951 (2015).","DOI":"10.1016\/j.bmcl.2015.03.022"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ahlstr\u00f6m MM, Ridderstr\u00f6m M, Zamora I, Luthman K. CYP2C9 Structure\u2009\u2212\u2009Metabolism Relationships:\u2009Optimizing the metabolic stability of COX-2 inhibitors. <i>J. Med. Chem.<\/i>, <b>50<\/b>, 4444\u20134452 (2007).","DOI":"10.1021\/jm0705096"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Chandna N, Kumar S, Kaushik P, Kaushik D, Roy SK, Gupta GK, Jachak SM, Kapoor JK, Sharma PK. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors. <i>Bioorg. Med. Chem.<\/i>, <b>21<\/b>, 4581\u20134590 (2013).","DOI":"10.1016\/j.bmc.2013.05.029"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. <i>J. Comput. Chem.<\/i>, <b>31<\/b>, 455\u2013461 (2010).","DOI":"10.1002\/jcc.21334"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera\u2014A visualization system for exploratory research and analysis. <i>J. Comput. Chem.<\/i>, <b>25<\/b>, 1605\u20131612 (2004).","DOI":"10.1002\/jcc.20084"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Blobaum AL, Marnett LJ. Structural and functional basis of cyclooxygenase inhibition. <i>J. Med. Chem.<\/i>, <b>50<\/b>, 1425\u20131441 (2007).","DOI":"10.1021\/jm0613166"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A. Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells. <i>Pharmacol. Res.<\/i>, <b>65<\/b>, 137\u2013148 (2012).","DOI":"10.1016\/j.phrs.2011.09.009"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/9\/44_b20-00991\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T04:16:14Z","timestamp":1630728974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/9\/44_b20-00991\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00991","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"article-number":"b20-00991"}}